Proper Cut-off Value of Free to Total PSA Ratio for Detection of Prostate Cancer in Korean Men

다국어 초록 (Multilingual Abstract)

To assess whether the free-to-total prostate specific antigen (PSA) ratio (F/T PSA ratio) would enhance prostate cancer detection in Korean men with serum total PSA levels between 4 and 20ng/ml. Methods: A total of 240 consecutive patients whose serum PSA levels were between 4 and 20ng/ml were enrolled in this two-year study. All patients underwent ultrasound-guided transrectal biopsies of the prostate gland. The F/T PSA ratio was measured using the Roche immunoassay. Results: Of the 240 patients, 202 (84%) had benign histologies, while 38 (16%) had prostate cancer. The two patient groups were well matched for age. The mean F/T PSA ratio showed a statistically significant difference between the two groups: in the benign histology group it was 0.14 (0.04-0.37), and 0.10 (0.08-0.20) in the prostate cancer group (p<0.05). Out of the 183 patients with a PSA level between 4-10ng/ml, the mean F/T PSA ratios were 0.14 and 0.11 in the benign histology (n=158) and prostate cancer groups (n=25), respectively (p<0.05). From the 57 patients with a PSA level between 10-20ng/ml, the mean F/T PSA ratios were 0.14 and 0.10 in the benign histology (n=44) and prostate cancer groups (n=13), respectively (p<0.05). Overall, when the cut-off value of the F/T PSA ratio was 0.10, the sensitivity and specificity were 75.0% and 76.5%, while for the cut-off value of 0.15 they were 83.3% and 39.7% respectively. Conclusion: Our data demonstrated the usefulness of the free to total PSA ratio in distinguishing benign prostate disease and cancer disease, hence eliminating unnecessary biopsies. It is recommended that a cut-off value for the F/T PSA ratio of 0.10 be applied to Korean men which this is lower than the value used in Western countries.

참고문헌 (Reference)

1 "Use of percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter trial" 279 : 1542-1547, 1998

2 "The use of prostate specific antigen density to enhance the predictive value of intermediate levels of serum prostate specific antigen" 147 : 817-821, 1992

3 "The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels" 154 : 1070-1073, 1995

4 "The clinical value of the ratio of free prostate specific antigen to total prostate specific antigen" 31 : 675-680, 1993

5 "Survey of incidence of urological cancer in South Korea: a 15-year summary" 9 : 445-454, 2002

6 "Significance of serum free prostate specific antigen in the screening of prostate cancer" 156 : 1964-1968, 1996

7 "Serum prostate specific antigen in a community-based population of healthy man. Establishment of age-specific reference ranges" 270 : 860-864, 1993

8 "Serum prostate specific antigen as prescreening test for prostate cancer" 147 : 846-851, 1992

9 "Serum concentrations of prostate specific antigen and its complex with a-1-antichymotrypsin before diagnosis of prostatic cancer" 344 : 1594-1598, 1994

10 "Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate" 43 : 601-606, 1994

11 "Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate" 145 : 907-923, 1991

12 "Prostate specific antigen predominantly forms a complex with a1- antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum" 70 : 230-234, 1992

13 "Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer" 147 : 815-816, 1992

14 "Prostate specific antigen density of transition zone: a new effective parameter for prostate cancer prediction" 157 : 1315-1321, 1997

15 "Longitudinal analysis of serial measurements of free and total PSA among men with and without prostatic cancer" 48 : 4-9, 1996

16 "Free/total PSA ratio is a powerful predictor of future prostate cancer morbidity in men with initial PSA levels of 4.1 to 10.0ng/ml" 61 : 760-764, 2003

17 "Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening" 274 : 1214-1220, 1995

18 "Ethnic differences in the age-related distribution of serum prostate specific antigen values: a study in a healthy Korean male population" 56 : 1007-1010, 2000

19 "Distribution of serum prostate specific antigen in healthy Korean men: influence of ethnicity" 60 : 475-479, 2002

20 "Diagnostic value of prostate-specific antigen- related parameters in discriminating prostate cancer" 7 : 409-414, 2000

21 "Characteristics of prostate cancer detected in the American Cancer Society-National Prostate Cancer Detection Project" 152 : 1737-1740, 1994